CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to assess the safety and tolerability of EI-1071 and the effects of EI-1071 on neuroinflammation in patients with mild, moderate, or severe Alzheimer's...
Phase 2
Taipei, Taiwan and 1 other location
The study medicine GSK4527226 is being studied in participants with Alzheimer's Disease (AD) in study 219867 (the parent study, NCT...
Phase 2
Taoyuan District, Taiwan and 19 other locations
This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies...
Phase 2, Phase 3
Taipei, Taiwan and 139 other locations
The purpose of this study is to assess the efficacy and safety of trontinemab in participants with early symptomatic Alzheimer's disease...
Phase 3
Taipei, Taiwan and 68 other locations
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease...
Phase 3
Taipei, Taiwan and 178 other locations
phase 2, randomized, double-blind, placebo-controlled study of oral EX039 as add-on to Acetylcholine Esterase Inhibitors in subjects with mild Alzheimer's...
Phase 2
Taipei, Taiwan
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...
Phase 3
Taipei, Taiwan and 264 other locations
The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The stu...
Phase 3
Taipei, Taiwan and 143 other locations
The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's...
Phase 3
Taipei, Taiwan and 155 other locations
This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants w...
Phase 3
Taipei, Taiwan and 490 other locations
Clinical trials
Research sites
Resources
Legal